Jump to Content Jump to Main Navigation Jump to Sub-Navigation
Key Contacts
Shahab Fatheazam
Managing Director
T: (312) 212-8220
e-mail
Arthur S. Kirsch
Managing Director
T: (212) 999-7080
e-mail
John C. Riddle
Managing Director
T: (312) 212-8230
e-mail
James B. Avery
Managing Director
T: (415) 318-3660
e-mail

Healthcare

GCA Savvian is well positioned to provide companies across the healthcare spectrum with sound judgment and innovative solutions in this constantly changing industry.

We deliver valuable insights into the effects that innovative healthcare models and technologies have on the continuum of care.

We bring 70 years of combined experience providing financial, strategic, and broad-level advisory services to the middle market, high-growth, specialty providers and service company segments.

The GCA Savvian Healthcare team focuses primarily on three sectors of the healthcare industry: Diagnostics and Research Tools, Medical Technology and Devices, and Healthcare Services.

Selected Transactions

CardioDynamics International Corporation
Acquired by
SonoSite, Inc.
 
American Diagnostica Inc.
Acquired by
Sekisui Chemical Co., Ltd.
 
Marketing Technology Solutions Inc.
Minority Preferred Investment by
WebMD Health Corp.
 
Vista HealthCare, LLC
Debt Refinancing
 
XenoTech L.L.C.
Acquired by
Sekisui Chemical Co., Ltd.
 
Health Contact Partners, Inc.
Acquired by
Trustmark Insurance Company
 
AcryMed, Inc.
Acquired by
I-Flow Corp.
 
HealthTalk
Acquired by
Revolution Health Group LLC
 
Cholestech Corporation
Acquired by
Inverness Medical Innovations, Inc.
 
SonoSite, Inc.
Convertible Notes
 
Healthline Networks, Inc.
Preferred Stock
 
CarePages, Inc.
Acquired by
Revolution Health Group LLC
 
Encorium Group
Common Stock PIPE
 
Quality Care Solutions, Inc.
Acquired by
The TriZetto Group, Inc.
 
Remedium Oy
Acquired by
Covalent Group, Inc.
 
BioLabs, Inc.
Debt and Equity Raise
 
WestCliff Medical Laboratories
Acquired by
BioLabs, Inc.
 
Health Line Clinical Laboratories
Acquired by
BioLabs, Inc.
 
Xylos Corporation
Preferred Stock
 
PML Microbiologicals
Acquired By
Pelican Life Sciences, Inc.